EdgardoRiveraMD

Oncology • Kingman, AZ

Physician

Join to view full profile

Dr. Rivera is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rivera's full profile

Already have an account?

Office
3269 N Stockton Hill Rd

Kingman, AZ 86409
Phone+1 928-263-5666

Fax+1 928-692-4648

Education & Training

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1993 - 1996
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1990 - 1993
University of Puerto Rico School of MedicineClass of 1990

Certifications & Licensure

CA State Medical License 2006 - Present
AZ State Medical License 2011 - 2026
TX State Medical License 1992 - 2025
WV State Medical License 2009 - 2025
PR State Medical License 1996 - 2019
NY State Medical License 1983 - 2018
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

211 citations
Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma.
Lajos Pusztai, Peter Wagner, Nuhad K. Ibrahim, Edgardo Rivera, Richard L. Theriault
Cancer. 2005-08-15
426 citations
Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification
Andrew D. Seidman, Monica Fornier, Francisco J. Esteva, Lee Tan, Stamatina Kaptain
Journal of Clinical Oncology. 2001-05-15
375 citations
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3...
Miguel Martin, Frankie A. Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy
The Lancet. Oncology. 2017-12-01

Press Mentions

Cancer Research as a Care Option Expands in Arizona as KRMC Cancer Center Is Now Conducting Clinical TrialsJuly 17th, 2019